Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
about
sameAs
Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levelsModulation of Chemokine Responses: Synergy and CooperativityBiased and g protein-independent signaling of chemokine receptorsCCR2 acts as scavenger for CCL2 during monocyte chemotaxisChemokine interaction with synergy-inducing molecules: fine tuning modulation of cell trafficking.Structure-function relationship between the human chemokine receptor CXCR3 and its ligandsSpiral ligament fibrocyte-derived MCP-1/CCL2 contributes to inner ear inflammation secondary to nontypeable H. influenzae-induced otitis media.The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2).Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infectionExpression profiling of the cellular processes in uterine leiomyomas: omic approaches and IGF-2 association with leiomyosarcomas.Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgiaCCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue.Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTESCCL18 exhibits a regulatory role through inhibition of receptor and glycosaminoglycan binding.Chemokines: role in inflammation and immune surveillance.Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytesCXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism.Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewingChemokine receptor antagonists: a novel therapeutic approach in allergic diseases.Folding of newly translated membrane protein CCR5 is assisted by the chaperonin GroEL-GroES.Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (Mig, CXCL9).Multiple roles for chemokines in the pathogenesis of SIV infectionThe chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.Aspects on pathophysiological mechanisms in COPD.Role of eotaxin-1 signaling in ovarian cancerTargeting CCL11 in the treatment of ovarian cancer.Increased circulatory levels of fractalkine (CX3CL1) are associated with inflammatory chemokines and cytokines in individuals with type-2 diabetesIdentification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis.Potential Role of Chemokines in Fracture Repair.Mechanisms of Regulation of the Chemokine-Receptor Network.Homeostatic Eosinophils: Characteristics and Functions.Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation.Retrospective Proteomic Analysis of Cellular Immune Responses and Protective Correlates of p24 Vaccination in an HIV Elite Controller Using Antibody Arrays.The CC chemokine eotaxin (CCL11) is a partial agonist of CC chemokine receptor 2b.A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted PatientsChikungunya fever: focus on peripheral markers of pathogenesis.Phototherapeutic hardening modulates systemic cytokine levels in patients with polymorphic light eruption.CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/eotaxin-2.High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia.
P2860
Q24293495-C5D662A7-43CC-4828-BD6E-2E020166A98FQ26744643-05AF3B11-407A-4574-AAF5-2B4D23F34CDCQ26823970-25DED816-0CCE-4325-9BAD-802B9BB4EDBCQ27302859-A18022B0-1A11-4687-9329-FFE137267D3BQ27693462-FF686DC1-DB6B-47FB-B508-2B83D4D951CDQ28213616-92EA65BF-6161-4797-B0FA-F3F80C2FA7D8Q30478615-23D882E1-5247-4FFC-89B2-B5D32973471AQ33519162-35F3272C-23A5-4BD7-AFFD-081B93B34BA2Q33781375-890E96F6-8085-4EDB-8817-F225A3CC74EAQ33791430-9D6DCC4E-08C5-4CC1-B6BE-C52C4C3A52ADQ34222718-E0E14D00-DC4E-4C80-9255-230964B7CBEFQ34474720-1FDE25C3-63B0-4C37-A71F-2F9B5184EA2AQ34823587-759762E2-4079-405A-989D-198B8719BD79Q34951532-66FCDFC9-B401-444B-8066-A271BF37D1F8Q35579361-4BDFBF0B-46BC-48AB-B716-C4E642615857Q35683064-47783ABA-BA10-4203-B6A9-4DB8B764D241Q35847956-990034FF-0110-45F0-A22C-FFD7CF3701AEQ35849317-0E72BE1D-224A-4405-A346-310FFCD723C7Q35928530-199C22B9-8586-4D64-94C7-A528650D9F3CQ36301143-C98677CF-9F5E-4274-9DB0-E756B12167FEQ36604383-A6C6E9CD-C8ED-4B4A-BE94-03D720D83E86Q36634172-2BB199B8-6FED-4BBD-8D37-D39950239BEEQ36793120-A191FCEF-B8CC-4EF4-8D26-6C344A5E2208Q36909567-BFAE7995-95D6-439E-942E-CC38D2B70617Q37160334-ADEAD6C2-026D-46AA-9569-BF50B5FD69F3Q37670242-E9B43AD6-4145-4658-BAFD-D31F17A4A663Q37736855-D71C7CEC-6A35-41F8-9C55-8AF70E51778FQ38343397-0BF87482-64ED-4DAC-A9F4-EF51974437B5Q38345417-2C82197A-90DF-4D0A-B6F8-09327BE93299Q38902331-838309D7-AC34-4B3A-912C-0D8833879585Q39126530-D9C1621F-4DD8-4F1C-93E5-D47B0F4D82B1Q39458566-2E01FCD3-6CC0-447E-AA41-637BB0364933Q40428711-17827CF0-9EF4-4AC9-BD0B-64AFDCB44729Q40549933-71CD690F-6EF3-46CB-8B5C-165E5301A164Q40686255-9C376738-E229-4D9A-B695-BD6A662373A9Q42293325-8F2EFA71-E8DB-4E61-9431-8D607CF5EFCDQ42710574-DC815BAA-3FB4-4732-84F7-92D1E7CDC007Q43740154-1050225F-CB9D-440E-9E2B-7C0BA57A87ACQ44795042-3B11EDA4-C24D-40AE-AD32-9E47ACAF55DDQ46555325-49F20B2D-A8C0-49EB-81CD-D91012CA04B6
P2860
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@ast
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@en
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@nl
type
label
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@ast
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@en
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@nl
prefLabel
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@ast
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@en
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@nl
P2093
P3181
P356
P1433
P1476
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
@en
P2093
I Clark-Lewis
M Baggiolini
M Uguccioni
P304
P3181
P356
10.1182/BLOOD.V97.7.1920
P407
P577
2001-04-01T00:00:00Z